Polymerase Chain Reaction and Its Potential as a Pharmacokinetic Tool
- 1 November 1992
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 23 (5) , 321-327
- https://doi.org/10.2165/00003088-199223050-00001
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Identification of a new variant CYP2D6 allele lacking the codon encoding Lys-281: possible association with the poor metabolizer phenotypePharmacogenetics, 1991
- Phenytoin: Pharmacogenetic polymorphism of 4′-hydroxylationPharmacology & Therapeutics, 1990
- Detection of debrisoquine hydroxylation phenotypesThe Lancet, 1990
- Identification of the primary gene defect at the cytochrome P450 CYP2D locusNature, 1990
- Lung Cancer and the Debrisoquine Metabolic PhenotypeJNCI Journal of the National Cancer Institute, 1990
- Identification of human serum cholinesterase variants using the polymerase chain reaction amplification techniqueTrends in Pharmacological Sciences, 1989
- Diagnosis of Genetic Disorders at the DNA LevelNew England Journal of Medicine, 1989
- Methyltransferase pharmacogeneticsPharmacology & Therapeutics, 1989
- Primer-Directed Enzymatic Amplification of DNA with a Thermostable DNA PolymeraseScience, 1988
- Enzymatic Amplification of β-Globin Genomic Sequences and Restriction Site Analysis for Diagnosis of Sickle Cell AnemiaScience, 1985